The TMS device your provider uses significantly affects your treatment outcomes, yet many patients don’t realize meaningful differences exist between systems. Different TMS coils reach different brain depths, target different regions, and produce varying treatment effects even when treating the same condition. Understanding these distinctions before starting treatment helps you make informed decisions about where to receive care and what results you might reasonably expect.
TMS Technology Isn’t One-Size-Fits-All
Transcranial Magnetic Stimulation encompasses multiple device designs, each with distinct technical specifications affecting treatment delivery. The original figure-8 coil design, used in many standard TMS systems, creates focused stimulation in superficial brain regions about 1.5–2 centimeters beneath the scalp. This works well for certain applications where target areas sit close to the surface.
Deep TMS therapy uses H-coil designs that reach approximately 4–6 centimeters into the brain, accessing structures that standard coils cannot effectively stimulate (Deng et al., 2013). This depth difference matters because many brain regions involved in depression, anxiety, and other conditions sit beyond standard TMS reach. The anterior cingulate cortex, for example, plays essential roles in emotional regulation but remains largely untouched by superficial stimulation.
Coil design also affects stimulation width. Figure-8 coils produce highly focused stimulation in small areas, requiring precise positioning. H-coils create broader stimulation fields, covering larger brain regions with each pulse. Neither approach is inherently better—the optimal choice depends on which brain circuits you’re targeting and what your specific symptoms involve.
FDA clearances differ between systems and manufacturers. Each device receives approval for specific conditions based on clinical trial data submitted to regulators. A system cleared for depression treatment hasn’t necessarily demonstrated efficacy for OCD or other conditions, even if the same brain regions are involved. Checking which FDA clearances a clinic’s device holds ensures you’re receiving evidence-based treatment for your diagnosis.
Complete Mind Care of PA uses the BrainsWay Deep TMS system, which holds FDA clearances for major depressive disorder, obsessive-compulsive disorder, and smoking cessation. This H-coil technology reaches deeper brain structures than standard TMS, potentially addressing circuit dysfunction that superficial stimulation cannot access effectively. Our leadership team previously built Success TMS, growing it to 35 locations, bringing that extensive specialized experience to every patient’s treatment planning.
Questions About Treatment Protocols
TMS protocols vary in stimulation frequency, intensity, session duration, and total treatment length. High-frequency protocols (typically 10–20 Hz) generally increase brain activity in the targeted region. Low-frequency protocols (typically 1 Hz) tend to decrease activity. Your provider should explain which protocol they’re using and why it matches your specific presentation.
Some conditions respond better to certain frequencies. Depression treatment typically uses high-frequency stimulation to activate underactive prefrontal regions. Anxiety presentations might benefit from low-frequency protocols that calm overactive areas, though research continues evolving. The wrong frequency for your particular brain circuit dysfunction could theoretically worsen symptoms rather than improve them.
Treatment intensity, measured in percentage of motor threshold, affects how deeply the magnetic field penetrates tissue. Your motor threshold gets determined during the first session by identifying the minimum intensity that causes visible thumb movement when stimulating your motor cortex. Treatment then occurs at a percentage of this individualized threshold, ensuring adequate stimulation depth while avoiding discomfort.
Ask how many sessions the standard protocol involves and how long each lasts. Most depression protocols require 20–30 sessions over 4–6 weeks, with each session lasting 20–40 minutes. Shorter courses or fewer sessions might indicate protocols that haven’t demonstrated efficacy in FDA trials. Longer courses aren’t necessarily better but may reflect certain evidence-based approaches.
The Clinical TMS Society publishes consensus guidelines recommending specific protocols for various conditions based on research evidence (Perera et al., 2016). Providers following these guidelines demonstrate commitment to evidence-based practice rather than using experimental approaches without adequate supporting data. Don’t hesitate to ask whether the protocol matches established clinical standards.
Provider Experience and Training
TMS effectiveness depends significantly on provider skill and experience. Operating the device is relatively straightforward technically, but determining appropriate protocols, adjusting treatment based on patient response, and managing side effects requires clinical judgment that develops over time. Ask how many TMS patients your provider has treated and how long they’ve offered the service.
Board certification in psychiatry or neurology indicates formal training in brain function and mental health treatment. Psychiatric nurse practitioners with specialized training also provide excellent TMS care. The key qualification is understanding how psychiatric conditions manifest and how treatment adjustments might address specific symptom presentations. Complete Mind Care’s mental health team includes board-certified psychiatrists and PMHNPs with extensive TMS experience.
Some clinics train technicians to operate TMS devices under physician supervision. This model works well when the supervising physician remains actively involved in treatment planning and response monitoring. Problems arise when physicians order treatment but rarely see patients after the initial consultation. Ask whether you’ll see the same provider consistently or primarily interact with technical staff.
Experience with the specific device model matters. A provider highly experienced with standard TMS may need time to optimize Deep TMS protocols, as the technologies differ in targeting and effects. Conversely, a newer provider who trained exclusively on Deep TMS systems may excel with that specific technology. Ask about their experience with the particular device they’re using for your treatment.
Look for providers who’ve participated in TMS training programs or continuing education beyond basic device operation instruction. The field evolves rapidly, and maintaining current knowledge about protocol refinements and emerging applications indicates commitment to providing optimal care. Providers should readily discuss their background and training without defensiveness. You can also explore our provider collaboration and clinical data resources for more information on our evidence-based approach.
Understanding Success Rates and Expectations
Response and remission rates vary significantly between studies and real-world practice. Response typically means at least 50% symptom reduction, while remission means achieving minimal or no symptoms. For depression, TMS response rates range from 50–60%, with remission rates around 30–40% in clinical trials. Real-world effectiveness may differ based on patient selection and protocol adherence.
Ask your provider about their clinic’s specific outcomes data. Well-established programs track patient results and can share aggregate data about response rates for your particular condition. If a clinic cannot provide any outcomes information beyond citing published studies, they may lack sufficient experience to identify their own success patterns.
Individual response prediction remains imperfect. Certain factors suggest better TMS candidacy—shorter illness duration, less treatment resistance, and specific symptom patterns correlate with higher response likelihood. However, even patients with poor prognostic factors sometimes respond excellently, while seemingly ideal candidates occasionally don’t improve. Your provider should acknowledge this uncertainty rather than guaranteeing results.
Timeline expectations matter. Most people noticing improvement see initial changes within 2–3 weeks, with continued gains throughout treatment and afterward. If you’ve completed several weeks without any change, discussing protocol adjustments or considering whether TMS is effectively addressing your particular brain circuit dysfunction becomes important. As explored in our post on understanding the brain mapping process for TMS, personalized targeting can be key to optimizing outcomes. Providers should monitor progress systematically rather than waiting until the end of a full course to evaluate effectiveness.
Ask about maintenance treatment recommendations. Some people achieve lasting remission after one TMS course, while others benefit from periodic maintenance sessions every few months. Understanding the provider’s approach to long-term symptom management helps you plan realistically for ongoing care needs and costs.
Insurance Coverage and Cost Considerations
Insurance coverage for TMS varies significantly by diagnosis and plan. Most major insurers cover TMS for depression after medication trial failures, but coverage requirements differ regarding how many medications must fail first. Some plans require prior authorization approval before treatment begins, which can take weeks to process. Complete Mind Care works with most major insurance plans and handles authorization paperwork.
For conditions beyond depression, coverage becomes less predictable. OCD treatment TMS coverage is expanding but not universal. Anxiety, PTSD, and other applications often lack coverage even when treated off-label based on research evidence. Understanding your financial responsibility before starting treatment prevents unpleasant surprises.
Out-of-pocket costs for TMS typically range from several thousand to over ten thousand dollars for a full treatment course without insurance. Some clinics offer payment plans or financing options. If cost poses barriers, asking about available financial assistance programs or phased payment arrangements may help make treatment accessible.
Beware of clinics advertising dramatically discounted prices. Reputable TMS requires significant equipment investment, skilled staff, and proper patient monitoring. Unusually low prices might indicate inexperienced providers, outdated technology, or shortened protocols that don’t match evidence-based standards. Quality care costs appropriate amounts—neither exorbitantly expensive nor suspiciously cheap.
Insurance coverage often requires documentation of treatment resistance, meaning records showing inadequate response to multiple medication trials. Gathering this documentation before starting the insurance authorization process speeds approval. Your provider should guide you through requirements and help obtain necessary records from previous prescribers.
Safety Profile and Side Effect Management
TMS safety profile is well-established, with serious adverse events being extremely rare. The most significant risk is seizure, occurring in less than 0.1% of patients in clinical practice (Rossi et al., 2009). People with seizure history, certain medications lowering seizure threshold, or metal implants near the treatment site may not qualify for TMS. Thorough medical screening identifies these risk factors before treatment begins.
Common side effects are mild and temporary. Scalp discomfort at the coil site affects many patients initially, usually improving after the first week. Some people experience headaches during or after sessions, typically manageable with over-the-counter pain relievers. Ask your provider how they handle side effects and whether protocol adjustments can minimize discomfort while maintaining effectiveness.
Hearing protection is essential during treatment since the magnetic pulses create loud clicking sounds. Proper earplugs or headphones prevent potential hearing damage. Reputable clinics make hearing protection mandatory and check that you’re using it correctly at every session. If a clinic seems casual about hearing protection, consider this a red flag about their safety protocols.
Unlike medications, TMS doesn’t cause systemic effects throughout your body. You won’t experience weight changes, sexual dysfunction, gastrointestinal issues, or cognitive dulling. This distinction makes TMS particularly appealing for people who’ve struggled with medication side effects. The side effects that do occur remain localized to the treatment site and resolve quickly.
Mental health symptoms occasionally worsen during TMS treatment initiation as your brain adjusts to stimulation. This typically resolves within days, but close monitoring ensures problems get addressed promptly. Ask how frequently your provider checks in during treatment and what processes exist for reporting concerning symptoms between sessions.
Treatment Environment and Logistics
The treatment environment affects your comfort and willingness to maintain the rigorous schedule TMS requires. Visit the clinic before committing to treatment. Observe whether treatment spaces are private and comfortable or cramped and clinical. You’ll spend considerable time there over several weeks—the environment should feel calming rather than adding to your stress.
Location and scheduling flexibility matter practically. TMS requires frequent appointments, typically five days weekly for several weeks. Can the clinic accommodate your work schedule? Is the location convenient to your home or workplace? Complete Mind Care schedules patients from early morning (7 AM) through evening (8 PM) Monday–Thursday, with locations in both Horsham and Villanova to serve the greater Philadelphia area.
Ask about the clinic’s process for rescheduling if you need to miss a session. Life happens—illnesses, work conflicts, family emergencies. Flexibility in accommodating occasional reschedules without penalizing you or compromising treatment effectiveness indicates patient-centered care. Rigid policies that don’t account for real-world complications may set you up for treatment failure.
Transportation planning is essential since you’ll need to get to appointments consistently. While you can drive yourself to and from TMS (unlike treatments requiring sedation), fatigue or headaches occasionally make driving uncomfortable immediately after sessions. Having backup transportation options prevents missed appointments.
Some clinics provide amenities like beverage service, comfortable waiting areas, or entertainment options during treatment. These extras don’t affect clinical outcomes but do make the experience more pleasant. Weigh their importance to you against other factors like provider experience and device technology.
Red Flags to Watch For
Certain warning signs should make you reconsider a provider or seek second opinions. Guarantees of specific outcomes—”90% of our patients achieve remission”—represent either dishonesty or overconfidence. Results vary by individual, and reputable providers acknowledge this uncertainty while remaining optimistic about potential benefits.
Pressure to commit immediately without adequate time to consider your options or consult other providers suggests prioritizing business over patient welfare. Quality clinics welcome informed decision-making and don’t employ high-pressure sales tactics. You should feel supported in taking time to evaluate whether TMS fits your situation.
Reluctance to answer questions about technology, protocols, or success rates raises concerns about transparency. Providers should readily explain their approach and reasoning. If you feel dismissed or talked down to when asking legitimate questions, trust your instincts that something isn’t right.
Clinics advertising TMS for numerous off-label conditions without acknowledging the investigational nature of these applications may oversell the technology. While research supports TMS for various conditions, FDA clearances remain limited. Honest providers distinguish between established applications and emerging uses backed by preliminary evidence.
Unusually aggressive marketing claims—”cure depression permanently” or “completely natural with zero side effects”—distort reality. TMS is a valuable treatment option with good evidence supporting it, but it’s not a miracle cure and does carry some risks and side effects. Marketing that sounds too good to be true probably is.
FAQ
Q: Should I try another medication before considering TMS?
This depends on your specific situation and treatment history. If you’ve tried multiple medications without adequate results or experienced intolerable side effects, moving to TMS makes sense. If you’ve only tried one or two medications, exploring a few more options might be reasonable. Discuss your treatment resistance and goals with your provider to determine the best timing.
Q: Can I switch TMS providers mid-treatment if I’m unhappy?
Switching providers during treatment is technically possible but complicates continuity of care. Different clinics use different devices and protocols, making seamless transition difficult. If you’re genuinely concerned about your current provider’s competence or safety practices, switching makes sense. For minor dissatisfaction, discussing concerns directly with your provider often resolves issues more effectively.
Q: Does the TMS technician’s experience matter as much as the doctor’s?
Technician skill matters for treatment comfort and consistency, but the supervising physician’s expertise matters more for clinical decision-making. Well-trained technicians can operate equipment excellently, but protocol selection, dosing adjustments, and side effect management require clinical judgment from experienced prescribers. The ideal scenario involves both skilled technicians and actively engaged physicians.
Q: Should I get a second opinion before starting TMS?
Second opinions are always reasonable, especially for significant treatment decisions involving substantial time and cost commitments. Many people consult multiple TMS providers to compare approaches, technology, and comfort level. Reputable providers won’t be offended by this—they understand the importance of confident, informed decision-making.
Q: How do I verify a provider’s claims about their TMS outcomes?
Ask providers for their aggregate outcomes data—response and remission rates for patients similar to you. While patient privacy prevents sharing individual cases, established programs should track their results. You can also check online reviews, ask for patient testimonials, or request references from referring physicians who’ve seen multiple patients treated there.
Conclusion
Choosing a TMS provider requires evaluating technology, protocols, provider experience, and practical considerations beyond just geographical convenience. The device type, treatment approach, and clinical expertise all significantly impact your likelihood of symptom improvement. Taking time to ask detailed questions and compare options leads to better treatment decisions.
If you’re considering TMS for depression, anxiety, OCD, or other conditions, Complete Mind Care of PA offers Deep TMS using the BrainsWay system with board-certified providers experienced in treatment-resistant presentations. Schedule a consultation today by calling 215-254-6000 to discuss whether our approach matches your treatment needs.
References
Deng, Z. D., Lisanby, S. H., & Peterchev, A. V. (2013). Electric field depth-focality tradeoff in transcranial magnetic stimulation: Simulation comparison of 50 coil designs. Brain Stimulation, 6(1), 1–13. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868387/
Perera, T., George, M. S., Grammer, G., Janicak, P. G., Pascual-Leone, A., & Wirecki, T. S. (2016). The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulation, 9(3), 336–346. https://pubmed.ncbi.nlm.nih.gov/27090022/
Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology, 120(12), 2008–2039. https://pubmed.ncbi.nlm.nih.gov/19833552/
Roth, Y., Barnea-Ygael, N., Carmi, L., Schlesinger, D., Vadim, L., Zangen, A., & Zohar, J. (2021). Real-world efficacy of deep TMS for obsessive-compulsive disorder: Post-marketing data collected from twenty-two clinical sites. Frontiers in Psychiatry, 12, 724282. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413184/